Literature DB >> 28754488

Survey of distribution of seasonal influenza vaccine doses in 201 countries (2004-2015): The 2003 World Health Assembly resolution on seasonal influenza vaccination coverage and the 2009 influenza pandemic have had very little impact on improving influenza control and pandemic preparedness.

A Palache1, A Abelin2, R Hollingsworth2, W Cracknell3, C Jacobs4, T Tsai5, P Barbosa6.   

Abstract

There is no global monitoring system for influenza vaccination coverage, making it difficult to assess progress towards the 2003 World Health Assembly (WHA) vaccination coverage target. In 2008, the IFPMA Influenza Vaccine Supply International Task Force (IVS) developed a survey method to assess the global distribution of influenza vaccine doses as a proxy for vaccination coverage rates. The latest dose distribution data for 2014 and 2015 was used to update previous analyses. Data were confidentially collected and aggregated by the IFPMA Secretariat, and combined with previous IFPMA IVS survey data (2004-2013). Data were available from 201 countries over the 2004-2015 period. A "hurdle" rate was defined as the number of doses required to reach 15.9% of the population in 2008. Overall, the number of distributed doses progressively increased between 2004 and 2011, driven by a 150% increase in AMRO, then plateaued. One percent fewer doses were distributed in 2015 than in 2011. Twenty-three countries were above the hurdle rate in 2015, compared to 15 in 2004, but distribution was highly uneven in and across all WHO regions. Three WHO regions (AMRO, EURO and WPRO) accounted for about 95% of doses distributed. But in EURO and WPRO, distribution rates in 2015 were only marginally higher than in 2004, and in EURO there was an overall downward trend in dose distribution. The vast majority of countries cannot meet the 2003WHA coverage targets and are inadequately prepared for a global influenza pandemic. With only 5% of influenza vaccine doses being distributed to 50% of the world's population, there is urgency to redress the gross inequities in disease prevention and in pandemic preparedness. The 2003WHA resolution must be reviewed and revised and a call issued for the renewed commitment of Member States to influenza vaccination coverage targets.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  Monitoring and evaluation; Pandemic preparedness; Seasonal influenza; Vaccination coverage rates; Vaccination policy; Vaccine recommendations

Mesh:

Substances:

Year:  2017        PMID: 28754488     DOI: 10.1016/j.vaccine.2017.07.053

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  25 in total

1.  Influenza Hemagglutination-inhibition Antibody Titer as a Mediator of Vaccine-induced Protection for Influenza B.

Authors:  Benjamin J Cowling; Wey Wen Lim; Ranawaka A P M Perera; Vicky J Fang; Gabriel M Leung; J S Malik Peiris; Eric J Tchetgen Tchetgen
Journal:  Clin Infect Dis       Date:  2019-05-02       Impact factor: 9.079

2.  Immunogenicity of seasonal inactivated influenza and inactivated polio vaccines among children in Senegal: Results from a cluster-randomized trial.

Authors:  Mbayame Niang; Meagan E Deming; Deborah Goudiaby; Ousmane M Diop; Ndongo Dia; Aldiouma Diallo; Justin R Ortiz; Doudou Diop; Kristen D C Lewis; Kathryn E Lafond; Marc-Alain Widdowson; John C Victor; Kathleen M Neuzil
Journal:  Vaccine       Date:  2020-10-02       Impact factor: 3.641

3.  Seasonal influenza vaccination among older adults in Jordan: prevalence, knowledge, and attitudes.

Authors:  Mera Ababneh; Mutaz Jaber; Abeer Rababa'h; Faris Ababneh
Journal:  Hum Vaccin Immunother       Date:  2020-02-11       Impact factor: 3.452

4.  Clinician-initiated research on treating the host response to pandemic influenza.

Authors:  David S Fedson
Journal:  Hum Vaccin Immunother       Date:  2017-10-31       Impact factor: 3.452

5.  T resident helper cells promote humoral responses in the lung.

Authors:  Nivedya Swarnalekha; David Schreiner; Ludivine C Litzler; Saadia Iftikhar; Daniel Kirchmeier; Marco Künzli; Young Min Son; Jie Sun; Etori Aguiar Moreira; Carolyn G King
Journal:  Sci Immunol       Date:  2021-01-08

6.  Impact of the coronavirus disease 2019 epidemic and a free influenza vaccine strategy on the willingness of residents to receive influenza vaccines in Shanghai, China.

Authors:  Yehong Zhou; Jing Tang; Junjie Zhang; Qiangsong Wu
Journal:  Hum Vaccin Immunother       Date:  2021-02-12       Impact factor: 3.452

Review 7.  Assessing the Importance of Domestic Vaccine Manufacturing Centers: An Overview of Immunization Programs, Vaccine Manufacture, and Distribution.

Authors:  Emma Rey-Jurado; Felipe Tapia; Natalia Muñoz-Durango; Margarita K Lay; Leandro J Carreño; Claudia A Riedel; Susan M Bueno; Yvonne Genzel; Alexis M Kalergis
Journal:  Front Immunol       Date:  2018-01-18       Impact factor: 7.561

Review 8.  The faces of influenza vaccine recommendation: A Literature review of the determinants and barriers to health providers' recommendation of influenza vaccine in pregnancy.

Authors:  Kathleen F Morales; Lisa Menning; Philipp Lambach
Journal:  Vaccine       Date:  2020-06-02       Impact factor: 3.641

9.  Active surveillance of 2017 seasonal influenza vaccine safety: an observational cohort study of individuals aged 6 months and older in Australia.

Authors:  Alexis J Pillsbury; Catherine Glover; Peter Jacoby; Helen E Quinn; Parveen Fathima; Patrick Cashman; Alan Leeb; Christopher C Blyth; Michael S Gold; Thomas Snelling; Kristine K Macartney
Journal:  BMJ Open       Date:  2018-10-18       Impact factor: 2.692

10.  Seasonal influenza vaccination policies in the 194 WHO Member States: The evolution of global influenza pandemic preparedness and the challenge of sustaining equitable vaccine access.

Authors:  Kathleen F Morales; David W Brown; Laure Dumolard; Claudia Steulet; Alba Vilajeliu; Alba Maria Ropero Alvarez; Ann Moen; Martin Friede; Philipp Lambach
Journal:  Vaccine X       Date:  2021-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.